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Nuclear receptors (NRs) are transcription factors
activated by a multitude of hormones, other en-
dogenous substances, and exogenous molecules.
These proteins modulate the regulation of target
genes by contacting their promoter or enhancer
sequences at specific recognition sites. The iden-
tification of these response elements is the first
step toward detailed insight into the regulatory
mechanisms affecting a gene. We have developed
NUBIScan, a computer algorithm to predict DNA
recognition sites for NRs in the regulatory regions
of genes. The algorithm is based on weighted
nucleotide distribution matrices and combines
scores from both half-sites necessary for NR dimer
binding. It provides more specific identification of
functional sites than previous in silico approaches,
as evidenced by scanning published regulatory re-
gions of drug-inducible genes and comparing the
obtained predictions with experimental results. In
prospective analyses, NUBIScan consistently iden-
tified new functional NR binding sites in sets of
large sequences, which had eluded previous anal-
yses. This is exemplified by the detailed functional
analysis of the flanking region of two genes. This
approach therefore facilitates the selection of
likely sites of gene regulation for subsequent ex-
perimental analysis. (Molecular Endocrinology 16:
1269–1279, 2002)
THE LARGE FAMILY of intracellular receptors andtranscription factors collectively called nuclear re-
ceptors (NRs) has raised considerable research inter-
est in past years (1, 2). It comprises more than 300
members, which mediate transcriptional regulation of
target genes by binding to DNA response elements
(REs) in promoter or enhancer regions of the regulated
gene. Ligand binding of the receptor triggers the re-
cruitment of coactivators and dissociation of core-
pressors and leads to changes in chromatin structure.
This allows increased binding of the transcription ini-
tiation complex to the promoter and increases the
amount of mRNA transcribed from the gene (3, 4).
The ligands for NRs are extremely diverse, including
steroid hormones, vitamin D3, thyroid hormones, fatty
acids, eicosanoids, RA, bile acids, sterols, and numer-
ous drugs and other xenochemicals. Of particular re-
cent interest in pharmacogenomics are the xenobi-
otic- or drug-sensing receptors, constitutive andro-
stane receptor, pregnane X receptor, also termed
steroid and xenobiotic receptor or pregnenolone-
activated receptor (PXR/SXR/PAR), and chicken
xenobiotic receptor (CXR) (5, 6).
Cognate REs for NRs are repeats of single DNA
hexamers in a distinct arrangement toward each other
in terms of relative orientation and spacing. The hex-
amer half-sites have a canonical consensus sequence
of AG(G|T)TCA. Half-site repeats are categorized into
direct repeats (DRs) and palindromic inverted repeats
(IRs) or everted repeats (ERs). The majority of NRs
binds as homo- or heterodimers to these hexamer
repeats, each dimer partner interacting with one of the
hexamers (1). Variations in the half-site sequence, their
relative orientation, and the length of the spacer se-
quence allow for a wide range of different REs, en-
abling specific binding of a given receptor dimer to
multiple target genes with different affinities, as well as
giving rise to integration of different signaling path-
ways by competition of different receptors at a given
binding site (7).
Available laboratory techniques to identify likely REs
in target genes are tedious and time consuming and
include DNAse I-hypersensitivity assays, subfragmen-
tation, and reporter gene experiments. Bioinformatics-
based approaches could considerably facilitate these
studies, but present methods have been poor predic-
tors of NR REs because of a low degree of sequence
conservation of these elements. Here, we describe a
computer algorithm capable of predicting weakly con-
served recognition sites for transcription factors that
bind as dimers, such as NRs. Compared with present
approaches, our algorithm provides more specificity in
the recognition of putative NR REs, making the anal-
ysis of large stretches of genomic sequences feasible.
The algorithm is based on weighted nucleotide distri-
bution matrices and the combined analysis of both
half-sites of the RE. We have named this data-mining
tool NUBIScan for “nuclear receptor binding site
scanner.”
Abbreviations: CAT, Chloramphenicol acetyltransferase;
CXR, chicken xenobiotic receptor; CYP, cytochrome P450;
DR, direct repeat; ER, everted repeat; GE, glutethimide;
GLUT2, glucose transporter 2 gene; IR, inverted repeat;
MDR1, multidrug resistance gene 1; NR, nuclear receptor;
PB, phenobarbital; PBRU, phenobarbital response unit; PXR,
pregnane X receptor; RE, response element; XREM, xenobi-
otic-responsive enhancer module.
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To assess the validity of predictions by this algo-
rithm, we have analyzed the sequences of three genes
known to be regulated by NRs and compared our
findings to experimental evidence. Moreover, we have
used NUBIScan as a tool to identify new functional NR
REs in the chicken cytochrome P450 (CYP) 2H1 and
3A37 genes. We find that the predictions obtained with
the NUBIScan algorithm correlate well with experi-
mental findings and provide an efficient way to select
putative regulatory regions in large genomic se-
quences for experimental analysis.
RESULTS AND DISCUSSION
Testing the Algorithm with Known REs
To assess the validity of predictions by the NUBIScan
algorithm, known REs for NRs discovered by classical
methods were used as test cases. Results are sum-
marized in Table 1.
First, we examined the 5-flanking region of the hu-
man multidrug resistance gene 1 (MDR1). MDR1
codes for P-glycoprotein, an efflux pump responsible
for actively moving hydrophobic compounds out of
cells. It is considered to be a first defense mechanism
against potential toxic substances and was initially
discovered in cancer cells as a resistance mechanism
against cytostatic drugs. P-glycoprotein is found in
intestine, liver, kidney, and the blood-brain barrier.
Intestinal MDR1 expression was shown to be inducible
by an array of compounds similar to those mediating
induction of the human CYP3A4 gene via PXR/RXR (8).
More recently, Geick et al. (9) have published a PXR/
RXR RE in the 5-flanking region, mediating drug in-
duction of the human MDR1 gene.
For our analysis, we have selected 28630 bp from
a bacterial artificial chromosome clone sequence
(GenBank accession no. AC002457), corresponding to
the sequence between the end of the upstream gene’s
coding sequence and the beginning of the MDR1 cod-
ing sequence.
Within this sequence, we scanned for high-scoring
matches to DR4, DR3, and ER6 motifs, using the ma-
trix described in Fig. 1. These motifs are known to be
recognized by PXR/RXR and have been found in the
MDR1 RE. The functional DR4(I) element (9) had the
best DR4 match with a Z score of 10.23 (Fig. 2A). An
ER6 motif, which binds PXR/RXR heterodimers in
vitro, was predicted as the second-best ER6. Two
further DR4 elements, DR4(II) and DR4(III), which could
not be shown to be functional, are found on the 17th
rank with identical Z scores of 6.94. Also, a DR3 ele-
ment found in the sequence but shown to be ineffec-
tive was found at third rank with a Z score of 7.59
(Fig. 2A).
Next, we investigated the flanking region of the hu-
man CYP3A7 gene (10). In analogy with the closely
related CYP3A4, the regulation of CYP3A7 was found
to be mediated by PXR chiefly through a distal xeno-
biotic-responsive enhancer module (XREM) at 8 kb
and to a small extent through a previously published
PXR binding site at –153 bp in the proximal promoter
(10, 11). The XREM is made up of an ER6 and a DR3
element in close association, which were termed
Table 1. Predicted NR REs in Regulatory Regions of Various Genes
Gene Lengtha Receptor Site Type
Predicted RE
Rankc Z Score Reporterd TAe EMSAf Mutationg
Position Nameb
MDR1 28.6 kb PXR/RXR DR4 8544 DR4(I) 1 10.23 F ND F F
ER6 8521 ER6 2 7.07 NF ND F F
DR3 8544 DR3 3 7.59 NF ND NF NF
CYP3A7 11.2 kb PXR/RXR DR3 7748 dNR1 1 8.76 F ND ND ND
ER6 7718 dNR2 2 7.42 F ND ND ND
221 pNR 3 7.38 Weak F F F
GLUT2 5.2 kb PPAR/RXR DR1 68 PPARE 1 7.19 ND F F F
CYP3A37 3.4 kb CXR/RXR DR4 1082 159-bp PBRU 1 8.52 F F F F
CYP2H1 4.8 kb CXR/RXR DR4 1636 264-bp PBRU 1 8.92 F F F F
4198 ND 2 8.14 NF ND ND ND
4974 240-bp PBRU 3 7.02 F F F F
1906 ND 4 6.74 NF ND ND ND
1519 264-bp PBRU 5 6.56 F F F F
F, Functional; NF, not functional; ND, not determined.
a Length of analyzed sequence.
b According to original publication.
c In a list of predictions sorted descending by Z score.
d Activity of element in reporter gene assays.
e Activity of element in transactivation assays.
f Ability of element to bind the receptor dimer in EMSAs.
g Stated as functional if mutation of the element was shown to abolish either activity in reporter gene assays or transactivation
assays or binding in EMSAs.
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dNR1 and dNR2. In the proximal promoter, another
ER6, termed pNR, is located.
We analyzed 11.2 kb of the CYP3A7 promoter
(GenBank accession no. AF329900) for DR3 and
ER6 repeats (Fig. 2B). The functional dNR1 site was
found as the best match (Z score 8.67). In contrast,
the inactive dNR3 site, located 400 bp downstream
from the XREM, attained a Z score of only 3.75.
Searching for ER6-type REs, the dNR2 site was the
second-best match, followed by the pNR site. No-
tably, the best-scoring ER6 element is located only
100 bp upstream from the dNR2 site, and it is pos-
sible, but untested so far, that this element contrib-
utes to the activation mediated by the (extended)
XREM.
Because the underlying nucleotide distribution
matrix defines what type of REs are recognized by
the algorithm, it can be adapted to recognize REs for
various receptors. To demonstrate this possibility of
extension and adaptation, we have compiled a set of
specific matrices for the - or -subtypes of the
PPAR from experimental data by Juge-Aubry et al.
(12), weighted according to the ability of the hex-
amer sequences to bind either receptor isoform in
vitro. As a test case for these matrices, we chose the
rat glucose transporter 2 gene (GLUT2/SLC2A2).
GLUT2 is a low-affinity facilitative glucose trans-
porter, present in pancreatic -cells, hepatocytes,
as well as intestine and kidney epithelial cells. A role
for GLUT2 as glucose sensor in pancreatic -cells
stimulating insulin release has been proposed: ho-
mozygous GLUT2 null mice show hyperglycemia
and relative hypoinsulinemia (13). Furthermore, tro-
Fig. 1. Contributing Sequences and the Derived Matrix
In panel A, the sequences that were used in the construction of the weighted stochastic matrix are shown. In total, 11
experimentally verified half-site sequences were taken from the literature. Although five sequences are representative of NRs in
general (half-sites 6, 7, and 9–11), six half-site sequences were chosen that are implicated in drug-mediated transcriptional
regulation. In this way, balance between general validity of the model and propensity to recognize REs implied in drug-mediated
induction was attempted. In panel B, the matrix calculated from the 11 half-site sequences of panel A is shown. pi(A) through pi(T),
Probability of nucleotide at position i of the matrix. Wi, Weight of position i, i.e. degree of conservation at position i of the matrix.
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glitazone, an antidiabetic agent that increases glu-
cose tolerance and insulin sensitivity, has previously
been shown to be an activator of PPAR and to
increase GLUT2 protein levels (14, 15). Recently, a
functional PPAR RE was identified in the 5-part of
the GLUT2 gene (16).
Fig. 2. Distribution of Scores of Predicted NR REs in the Flanking Regions of the Human MDR1 and CYP3A7 Genes and the Rat
GLUT2 Gene
Bold arrows depict functional NR half-sites; dashed arrows mark half-sites initially suspected, but experimentally disproven in
the original publications. A, 28,630 bp of MDR1 5-flanking region sequence were analyzed with NUBIScan for matches to DR4,
DR3, and ER6 NR binding sites. Threshold was set to 0, and the frequency of resulting Z scores was plotted. B, Analysis of 11.2-kb
5-flanking region of the human CYP3A7 gene for occurrences of DR4 and ER6 type sites. N, Number of investigated possible
REs. C, Analysis of the rat GLUT1 gene flanking region (5192 bp) for PPAR sites (DR1). For this analysis, a weighted matrix was
constructed from experimental data by Juge-Aubry et al. (12). Data were plotted as in panels A and B.
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We screened 5192 bp of the 5-part of the GLUT2
gene (GenBank accession number: L28126) for DR1
elements, the cognate REs for PPAR. The functional
PPAR RE was the best match with a Z score of 7.19
when using a matrix specific for PPAR (Fig. 2C), and
with a Z score of 7.13 when using a matrix geared
toward PPAR (not shown). This difference in match
quality may be reflected in the activation potential of
these two receptors: whereas PPAR activated the RE
efficiently in transactivation assays, PPAR activated
the element to a much lesser extent (16).
These exemplary applications show that prediction
of functional NR REs is possible in sequences as long
as 30 kb. It must be emphasized that the Z score of a
match is a measure of the resemblance to known
functional sites but does not prove function, which
depends on additional variables.
The Algorithm as a Predictor of Binding Sites
After proving that the NR REs predicted by our algo-
rithm correlate well with functional binding sites in
characterized regulatory regions, we applied NUBIScan
to previously uncharacterized regulatory regions and
tested the predictions.
We searched for REs in the recently characterized
chicken CYP3A37 gene, the expression of which is
increased by prototypical inducers of the CYP3A gene
family in ovo and in LMH chicken hepatoma cells (17).
From a chicken genomic library, we isolated a cosmid
clone containing all CYP3A37 exons and flanking re-
gions. We have subcloned and sequenced 3.1 kb of
upstream sequence.1 Because CYP3A37 is induced
by a range of drugs and steroids that were shown to
activate the chicken xenobiotic receptor CXR (6, 17),
we surmised that CXR is the receptor mediating in-
duction of this gene. Therefore, we scanned the up-
stream sequence with NUBIScan for DR4-type CXR
REs, using the matrix described in Fig. 1. The best-
scoring match (Z score, 8.72) was located at 1082
bp (Table 1). Concurrent with in silico analysis, the
upstream region was subfractionated into smaller
pieces, which were cloned into the pBLCAT5 chlor-
amphenicol acetyl transferase (CAT) reporter gene
vector. These constructs were tested for inducibility in
LMH cells. The site conferring drug inducibility coin-
cided with the predicted DR4-type binding site (Fig.
3A). Based on these results, we have defined a phe-
nobarbital response unit (PBRU), able to confer drug
induction, which is 159 bp in length, encompassing
the predicted binding site (Fig. 3B). Site-directed mu-
tagenesis of one of the predicted half-sites abolished
drug induction completely. Mutation also abolished
activation by CXR in transactivation assays (Fig. 3C)
and prevented binding of CXR/RXR to the site in
EMSAs (Fig. 4).
Finally, we have applied our algorithm to the analy-
sis of a drug-inducible 4.8-kb BamHI fragment (Gen-
Bank accession no. AF236668) located upstream of
the chicken CYP2H1 gene. From previous experi-
ments, we could correlate the predictions of the algo-
rithm with a comprehensive set of experimental data
(18). Two PBRUs in this sequence have been shown to
be activated by CXR, binding to cognate DR4 ele-
ments within the PBRUs (6, 19).
A search for DR4 repeats using the previously used
matrix (see Fig. 1) yielded five predicted REs with a Z
score higher than 6.5 (Table 1). The best-scoring result
(Z score 8.92) is the DR4 element essential for drug-
induced activation of the 264 bp, as shown by site-
directed mutagenesis (18). While the second- and
fourth-best results concern fragments unresponsive in
reporter gene assays, the third-best match colocalizes
with the DR4 described as necessary for CXR binding
and drug-mediated induction in the 240-bp PBRU (19).
The fifth predicted RE lies within the previously de-
scribed 264-bp PBRU (Fig. 5A) and may explain the
weak residual induction previously observed after mu-
tation of the other DR4 element in this PBRU. To study
the relative function of the two REs in more detail, we
created mutants of the 264-bp PBRU. In addition to
the previously described mutant of the 264-bp PBRU,
where the NR1 site is mutated (18), we mutated both
half-sites of the NR2 site in wild-type and NR1 con-
structs, as depicted in Fig. 5B. We tested these con-
structs in reporter gene assays in LMH cells. Induc-
ibility was measured after treating the cells for 24 h
with 400 M phenobarbital (PB), 500 M glutethimide
(GE), or vehicle alone (0.1% dimethylsulfoxide) (Fig.
5B). Mutation of the upstream DR4 element (NR1)
profoundly reduced drug inducibility conferred by the
element (from 74.5-fold to 6.5-fold for GE) but did not
abolish it completely. Only additional mutation of the
downstream DR4 (NR1NR2) completely abolished
induction, suggesting functional roles for both DR4
elements in the 264-bp PBRU. Interestingly, mutation
of only the downstream RE (NR2) led to very similar
results as observed with mutation of the upstream
element (NR1). Inducibility was greatly reduced (from
74.5-fold to 4.3-fold for GE). This attributes important
roles in induction to both REs in the 264-bp PBRU.
The interaction between CXR and the two DR4 ele-
ments was studied in transactivation assays in CV-1
monkey kidney cells. Cells were transfected with CXR
expression plasmid in addition to the reporter con-
structs and exposed to 10 M clotrimazole and other
drugs as indicated. The effects of the mutations on
transactivation by CXR were identical with the reporter
gene results in LMH cells (Fig. 5C).
In EMSAs, we then determined whether CXR/RXR
can still bind to the mutant PBRUs (Fig. 6). Radiola-
beled wild-type probe could be efficiently displaced by
cold wild-type competitor, but not with the NR1 mu-
tant. NR2 competitor also displaced the wild-type
probe quite efficiently, whereas the combined
1 These sequence data have been submitted to the DDBJ/
EMBL/GenBank databases under accession no. AF486653.
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NR1NR2 mutant did not compete with the probe.
When wild-type and mutant PBRUs were radiolabeled
and used as probe, strong binding of CXR/RXR het-
erodimer was observed to the wild-type probe and to
the NR2 probe. NR1 could still weakly bind the
receptors, and with the NR1NR2 mutant, no bind-
ing at all was observed.
The NR1 and NR2 sites exhibit different affinities for
CXR/RXR in vitro, NR2 interacting much more weakly
with the receptors. However, both sites seem to con-
tribute equally to the induction of the 264-bp PBRU, as
witnessed in the experiments with single-site mutant
constructs. Based on these data, we hypothesize that
the observed synergistic effect is not likely to be
caused at the level of DNA interaction, but happens
later on, e.g. in the recruitment of coactivators. With
the identification of a second DR4 element in the
chicken CYP2H1 PBRU—in analogy to the PBRUs
found in mouse, rat, and man (20)—the notion of evo-
lutionary conserved drug-response signaling path-
ways put forward in Ref. 21 is corroborated.
In conclusion, application of the NUBIScan algo-
rithm to this well characterized regulatory region
thus has verified the usefulness of the algorithm in
determining likely sites of regulation by NRs. Not
unexpectedly, not all predicted sites mapped to dis-
tinctly drug-inducible fragments of the CYP2H1
flanking region. Recognition and transactivation by
NRs depends on more than the core binding site,
such as three-dimensional DNA structure, acces-
sory binding sites, and surrounding sequences, fac-
tors not accounted for in the present model. Never-
theless, among the five best matches, the majority
of the predictions were positive, and this refined in
Fig. 3. Isolation of a Drug-Responsive Element from the CYP3A37 Gene
A, Subfragmentation of the drug-responsive 3.1-kb element. The gray box indicates the predicted DR4 site. Fragments were
transiently transfected into LMH cells, and induction was measured after 24 h induction with the indicated compounds. In the
159HS1 construct, the DR-4 element was destroyed by site-directed mutagenesis. B, Sequence of the 159-bp PBRU. The gray
box indicates the DR4-type NR binding site, consisting of two hexamer half-sites designated by arrows. C, Wild-type and mutant
159-bp PBRUs were cotransfected with a CXR expression plasmid into a priori non-drug-responsive CV-1 cells. After transfec-
tion, cells were induced for 24 h with the indicated compounds. Data shown are the average of three independent experiments.
Error bars represent 1 SD.
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silico analysis has led to the discovery of a further
RE in the 264-bp PBRU, which had eluded previous
studies and computer analyses.
Advantages and Limitations of the
NUBIScan Algorithm
The present algorithm clearly provides more specificity
than an approach based on matching consensus pat-
terns. Already in generating a consensus pattern,
much of the information about nucleotide frequency
contained in an aligned set of RE sequences is dis-
carded. When searching with a consensus, then, again
information is lost, because only a match/no match
decision can be made. In contrast, an approach using
comparisons to a nucleotide frequency matrix con-
serves frequency information from the set of REs and
furthermore, leads to differentiated quality scores for
each match and thus retains more specificity (22).
Presently available matrix-based approaches for the
prediction of transcription factor-binding sites, such
as the MatInspector algorithm (23), are designed to
cover a large number of different protein-DNA inter-
actions and do not consider all aspects of the internal
structure of a particular binding site. The here de-
scribed algorithm proved to be considerably more
efficient and specific in the detection of functional
NR REs.
Generally, detection of NR REs is hampered by the
low degree of sequence conservation among REs,
leading to low predictive power of the algorithm. As a
result, the researcher is often overwhelmed with a
wealth of putative REs, the quality scores of which are
very similar. Increasing the specificity of predictions
alleviates this problem.
Our approach focuses on a prediction of specific
combinations of two low-affinity binding sites, such as
NR binding sites. As a new concept, we consider each
half-site of the RE as a motif and then search for a
specific combination of these motifs. The net result of
this approach of combining two matches to a matrix is
that the mean score of all matches in a sequence
drops dramatically, because the score of weak
matches is decreased by the combination step,
whereas the score of good matches (close to 1) re-
mains nearly the same.
Using this combined scoring approach, a good half-
site can compensate to some extent for a weaker
half-site, an observation that was also made in exper-
imental analysis of NR binding sites (e.g. in Ref. 18).
It is clear, however, that an in silico approach can
never replace biological evidence for the functionality
of a predicted RE. Transcriptional activation is a dy-
namic, multiprotein process, which depends on further
factors such as chromatin structure; the sequences
surrounding the NR binding site are important for its
function. Because the algorithm focuses solely on the
hexamer cores, predicted REs thus may not be func-
tional in a native context. On the other hand, NRs have
been shown to act also indirectly by cooperation with
other proteins without contacting the DNA them-
selves. This level of regulation will be missed by our
algorithm; it can only predict REs that involve direct
receptor/DNA interaction.
Nevertheless, active REs were consistently found
among the top-scoring predictions, and an analysis
with NUBIScan is a time-efficient first approach to
highlighting regions of interest for further experiments.
The estimate of false positive or false negative pre-
dictions is strongly dependent on the cut-off chosen
for the Z score. With a threshold of 6.5 Z scores, we
have not yet detected a false negative result, i.e. a site
to which a receptor binds that is not detected. With the
same Z score, we have seen false positives in the
CYP2H1 flanking region, as discussed above.
Compared with three common approaches, visual in-
spection, pattern searches, and searches using the Mat-
Inspector algorithm (23), NUBIScan performs favorably:
visual inspection of the sequence is restricted to short
sequences. A pattern search approach based on degen-
erate consensus patterns will result in too many hits
without any means to quantitatively distinguish good and
poor matches. The MatInspector algorithm uses a data-
base of weighted nucleotide matrices. Unfortunately,
within the current release of the database, there are very
Fig. 4. CXR/RXR Binding to the CYP3A37 159-bp PBRU in
Vitro Is Dependent on the Presence of the DR4 Motif
A wild-type 159-bp fragment or 159-bp fragment, where
one of the two half-sites of the DR4 motif was altered to a
NotI restriction site, was radiolabeled and incubated with in
vitro transcribed/translated CXR, chicken RXR, or both.
Binding of the heterodimer to the probe results in a band shift
only with the wild-type fragment. When anti-RXR antibody
was added, this complex was supershifted. Arrows designate
free probe (FP), the complex of CXR, RXR, and probe (S),
and the complex of CXR, RXR, anti-RXR antibody, and
probe (SS).
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few matrices for NR REs. Moreover, analysis of large
genomic sequences (1000 bp) with MatInspector for
single transcription factors is not recommended by the
authors, as the predictive power of the algorithm is de-
creased by random matches that exceed the set thresh-
old. This is prevented in NUBIScan by the multiplicative
half-site combination step.
With this gain of specificity, achieved through the
modular approach of combining distinct, but related,
sites rather than using a larger, more variable region
spanning both half-sites, screening large sets of
genomic sequences for particular binding sites be-
comes feasible, where in our experience other pro-
grams fail to produce reliable results due to low spec-
ificity of the attained matches.
CONCLUSIONS
Responses to hormones and to environmental chal-
lenges are often mediated via enhancer elements that
can be many kilobases away from the transcriptional
start site and thus are difficult to detect and analyze. In
this large-sequence context, “eyeballing” of the se-
quence is impractical or impossible, and supplemen-
tation by a computational approach is highly desirable.
We have successfully applied the here described al-
gorithm to such large genomic sequences. The algo-
rithm can be adapted to specific recognition tasks by
using a different matrix, on the condition that the RE
consists of two distinct parts, as found with transcrip-
tion factors binding as dimers.
Although the algorithm obviously cannot replace ex-
perimental verification of the proposed sites of regu-
lation, it selects the set of sites most promising for
further investigation. Sequence information of genes
and their surrounding sequence is increasingly avail-
able for many genomes. A researcher interested in the
regulation of a specific gene can apply the algorithm to
mine this growing information base. This screening
method for target genes of a particular regulatory
pathway complements high-throughput approaches,
such as gene expression arrays.
Fig. 5. Mutational Analysis of the Two Functional CXR Binding Sites in the 264-bp PBRU
A, Sequence of the 264-bp CYP2H1 PBRU. Indicated as gray boxes are the two DR4-type NR binding sites, each
consisting of two hexamer half-sites designated by arrows. A putative NF-1 binding site is boxed. B, Effect of mutations on
the inducibility of the 264-bp PBRU: the proximal or distal DR4 element or both were destroyed by site-directed mutagen-
esis. The inducibility of wild-type and mutation constructs was tested in LMH cells in transient transfection experiments. C,
The same constructs were also cotransfected with CXR expression plasmid into CV-1 cells. After transfection, cells were
induced for 24 h with 400 M PB, 500 M GE, or 10 M clotrimazole. Data shown are the average of three independent
experiments. Error bars represent 1 SD.
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MATERIALS AND METHODS
Reagents
Unless specified otherwise, all chemical reagents were ob-
tained from Fluka/Sigma-Aldrich Corp. (Buchs, Switzerland)
and were of the highest grade available. Cell culture reagents
were obtained from Life Technologies, Inc. (distributed by
Invitrogen AG, Basel, Switzerland) unless stated otherwise.
Plasmid preparations were done with the QIAGEN (Basel,
Switzerland) system. The pBLCAT5 cloning vector was gen-
erously provided by Dr. G. Schu¨tz (German Cancer Research
Center, Heidelberg, Germany) and was described previously
(24).
Matrix Calculation
Initially, a nucleotide distribution matrix is constructed from a
set of aligned sequences, e.g. from a group of NR half-sites.
Subsequently, a position weight is calculated for each posi-









Equation 1: definition of matrix position weight according to
information content. Wi, weight at position i; b, base; pi(b),
frequency of base b at position i (taken from stochastic
matrix).
This position weight is arbitrarily scaled between 0 and
100, where 100 signifies a position with full sequence con-
servation throughout the training set and 0 signifies no con-
servation. Due to the positional weights of the matrix, more
conserved nucleotides are considered more important in the
analysis of a query sequence.
Scanning a Query Sequence for Potential NR
Binding Sites
To localize specific NR binding sites, NUBIScan searches for
two occurrences of the matrix within a specified distance,
having a defined relative orientation (DR, ER, or IR). These
parameters are defined before execution of the algorithm.
The comparison is a two-step process: initially, single scores,
i.e. quality scores for all possible matches on both strands of
the query sequence to the matrix, are calculated. Match
quality scores are expressed as ratio to the best attainable
match.
Shalfsite  j 
i1n Wi pi bjii1n Wi pi max
Equation 2: calculation of the half-site score at position j of
the query sequence. n, Length of matrix; Wi, matrix weight at
position i; bji, base at offset i from starting point of present
calculation (j); pi(bji ), nucleotide score; pi(max), maximal
nucleotide frequency found in the matrix at position i.
Finally, matrix matches are combined by multiplication to
give the score for the desired arrangement and spacing of
half-sites. Thus, SFull(j)  Shalf-site(j) * Shalf-site(j n) for position
j in the query sequence and a DR with n spacer nucleotides.
For ERs and IRs, scores from the sense and antisense strand
are combined analogously. Positions whose score is over a
predefined threshold value are included in a list of found
matches. This threshold can be set either as a final score or
as a Z score (i.e. a number of standard deviations from the
mean score of all possible sites in the sequence).
The core algorithm has been programmed in C as a com-
mand-line tool for Microsoft Corp. Windows and Unix plat-
Fig. 6. Mutation of the NR Binding Sites Affects CXR/RXR Binding to the CYP2H1 264-bp PBRU in Vitro
Lanes 1–3, Wild-type 264-bp PBRU (wt) was radiolabeled and incubated with in vitro transcribed/translated CXR and RXR
(lane 2) and additionally with anti-RXR antibody (lane 3). Lanes 4–7, Binding of CXR/RXR to the labeled wild type was competed
with 20-fold molar excess of wild-type fragment or fragments mutated in the NR1 (1), NR2 (2), or both NR binding sites (12).
In lanes 9–12, wild-type and mutant fragments were incubated with CXR/RXR and binding of the receptors to the fragments was
assayed. Arrows designate free probe (FP), the complex of CXR, RXR, and probe (S), and the complex of CXR, RXR, anti-RXR
antibody, and probe (SS).
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forms. A web interface for the algorithm was programmed in
Perl.
The algorithm is shown in detail in the supplemental data
to this paper published on The Endocrine Society’s Journals
Online web site, http://mend.endojournals.org/. In addition,
this algorithm is the core of a web interface that functions as
a central hub, providing background information and user
instructions as well as access to the programs. This web
interface is available to researchers from nonprofit and aca-
demic institutions at the following URL: http://www.
nubiscan.unibas.ch. It allows users to create their own matrix
files from sets of sequences and to scan query sequences
with their own matrices or with provided general-purpose
matrices.
Users can define a search strategy for their query se-
quence, so that a sequence can be scanned for different
arrangements of half-sites at the same time. In this way,
variations in the admissible half-site spacing for a given re-
ceptor can be accommodated. For each single search, a
threshold can be set either as absolute score or as Z score.
As a starting point, we recommend setting the threshold at
six to seven Z scores, and to examine the resulting predic-
tions subsequently in rank order.
Cloning and Mutagenesis of REs
CAT reporter gene plasmids containing subfragments of the
CYP3A37 5-flanking region were constructed by PCR and
subsequent restriction digestion (see Fig. 3). The 3096-bp
fragment was amplified by PCR using 5-ATC GGA TCC AGC
TGG GTG TAG GGT CCA T-3 and 5-ATC GGA TCC ACT
GGC CTC ATG TCC CGA-3 as sense and antisense primers,
creating a BamHI site on both ends to facilitate cloning.
From the 3096-bp fragment, the 1264-bp fragment was
excised using EcoNI and NsiI, religation resulting in the 874
bp  960 bp construct. The 1264-bp fragment was further
cut with AatII, resulting in the 896-bp and 368-bp fragment.
Finally, digestion with BspMI yielded the 212-bp and 159-bp
fragments. The DR4 site of the 159-bp PBRU was mutated
into a NotI restriction site by PCR using standard overlap
techniques as described previously (18). Thus, the DR4 was
altered from the wild-type 5-TGAACTGCGATGCACT-3 se-
quence to 5-gcggccGCGATGCACT-3 (altered bases are in
lowercase letters, the hexamer cores are represented in bold-
face). CAT reporter gene plasmids containing the wild-type
264-bp CYP2H1 PBRU or the 264-bp CYP2H1 PBRU with
the NR1 half-sites mutated were described (18). Briefly, the
NR1 site was changed from 5-GAACTTCCTTGCCCT-3 to
5-ccgcggTCCTgatatc-3, introducing SacII and EcoRV re-
striction sites. Mutants of the second NR site were done with
PCR overlap techniques. By changing the wild-type 5-
GGGTCCTGGGAGTTCA-3 sequence to 5-tctagaTGGG-
ctcgag-3, the half-sites were mutated into an XbaI and a
XhoI restriction site.
Cell Culture and Transient Transfection, EMSA
LMH chicken hepatoma cells were cultivated as previously
described (6). One day before transfection, the culture me-
dium was replaced with William’s E medium containing glu-
tamine and penicillin/streptomycin, supplemented with 10%
delipidated, charcoal-stripped FCS (Sigma, St. Louis, MO).
This change was observed to greatly increase the extent of
drug-mediated induction, presumably by the absence of in-
hibitory substances from the serum. Cells were transfected
with 1 g of reporter vector and 100 ng of pRSV--Galacto-
sidase (kindly provided by Dr. A. Kralli, Biozentrum, University
of Basel, Switzerland) vector per well, using FuGene6 trans-
fection reagent (Roche Molecular Biochemicals, Rotkreuz,
Switzerland) according to the manufacturer’s instructions.
Four hours after transfection, an appropriate dilution of the
inducer compounds was added to the wells, and cells were
incubated for an additional 24 h before preparation of cell
extracts to assay for reporter gene and -galactosidase ex-
pression. Transactivation assays in CV-1 monkey kidney
cells, reporter gene assays, and EMSAs were performed as
described before (6). Expression plasmids for CXR and
chicken RXR have been described (6). The monoclonal an-
timouse RXR rabbit antibody used for supershifts was kindly
provided by Dr. P. Chambon (Institut de Ge´ne´tique et de
Biologie Mole´culaire et Cellulaire, Universite´ Louis Pasteur,
Illkirch, France).
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